Medartis Holding AG/Fr. MED
1D1W1MYTD1Y5YMAX
About Medartis Holding AG
Medartis Holding AG is a Swiss company operating in the medical technology industry, primarily focused on the development, manufacturing, and distribution of orthopedic surgical implants. The company's core products include precision implant systems for surgical fixation of bone fractures and osteotomies, particularly in the areas of the head, hand, wrist, foot, and ankle. Founded in 1997 and headquartered in Basel, Switzerland, Medartis has established a presence in key international markets across Europe, the Americas, and Asia-Pacific. The company's strategic positioning emphasizes innovation in implant technology, aiming for high standards of surgical precision and patient recovery outcomes.
- Ticker
- Fr. MED
- Sector
- Health
- Primary listing
- XSWX
- Employees
- 1,428
- Headquarters
- Basel, Switzerland
- Website
- www.medartis.com
MED Metrics
BasicAdvanced
CHF 1.1B
77.65
CHF 1.20
1.17
-
Price and volume
Market cap
CHF 1.1B
Beta
1.17
52-week high
CHF 97.50
52-week low
CHF 70.60
Average daily volume
5.4K
Financial strength
Current ratio
3.361
Quick ratio
1.617
Long term debt to equity
69.774
Total debt to equity
73.531
Interest coverage (TTM)
2.58%
Profitability
EBITDA (TTM)
29.078
Gross margin (TTM)
77.48%
Net profit margin (TTM)
4.86%
Operating margin (TTM)
2.90%
Effective tax rate (TTM)
31.10%
Revenue per employee (TTM)
CHF 220,000
Management effectiveness
Return on assets (TTM)
1.03%
Return on equity (TTM)
5.75%
Valuation
Price to earnings (TTM)
77.646
Price to revenue (TTM)
3.769
Price to book
4.06
Price to tangible book (TTM)
32.26
Price to free cash flow (TTM)
-974.961
Free cash flow yield (TTM)
-0.10%
Free cash flow per share (TTM)
-0.095
Growth
Revenue change (TTM)
29.92%
Earnings per share change (TTM)
-2,486.22%
3-year revenue growth (CAGR)
15.81%
3-year earnings per share growth (CAGR)
29.85%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.